# Establishment of dry-chemistry-based reference intervals of routine liver function tests for the adult population of Gandaki Province, Nepal

**Authors:** Asmita Sharma, Daya Ram Pokharel, Ganesh Dhakal, Hugh Cowley, Jianhong Zhou, Julia Robinson

PMC · DOI: 10.1371/journal.pgph.0001865 · PLOS Global Public Health · 2024-05-09

## TL;DR

This study establishes new reference intervals for liver function tests specific to the adult population in Gandaki Province, Nepal, to improve medical accuracy and diagnosis.

## Contribution

The study provides population-specific reference intervals for liver function tests in Gandaki Province, Nepal, using dry-chemistry methods.

## Key findings

- New reference intervals for 11 liver function parameters were established for the Gandaki Province population.
- Significant differences in reference intervals were observed between males and females for several parameters.
- Up to 4–40% of healthy adults were misclassified as abnormal using existing reference intervals.

## Abstract

Every clinical laboratory should ideally establish its own population-specific reference intervals (RIs) to promote precision and evidence-based medicine. However, clinical laboratories in Nepal find it easier to follow external RIs than establish their own, leading to a lack of RIs specific to the local population. This study thus aimed to establish RIs of routine LFTs for the adult population of Gandaki Province, Nepal, and compare them with the current RIs used by our laboratory. We established the dry-chemistry-based reference intervals of 11 common LFT parameters for the adult population of Gandaki Province, Nepal using the direct priori-based method. The combined and sex-specific 95% double-sided RIs of total protein, albumin, globulin, A/G ratio, bilirubin, aspartate aminotransaminase (AST), alanine aminotransaminase (ALT), AST/ALT ratio, and alkaline phosphatase (ALP) were established using non-parametric percentile method. The new RIs were also compared with the currently used RIs that were adopted from the reagent kit inserts. The newly established RIs for each LFT were: Total proteins: 68.0–69.0g/L, albumin: 39.0–52.0g/L; globulin: 27.0–42.0g/L; A/G ratio: 1.1–1.8; total bilirubin: 5.13–25.65μmol/L (0.30–1.50mg/dl); unconjugated bilirubin: 1.71–17.10μmol/L (0.10–1.00mg/dl); conjugated bilirubin: 0.00–10.26 μmol/L (0.00–0.60mg/dl); AST: 20.0–43.2U/L; ALT: 11.0–53.0 U/L; AST/ALT ratio: 0.7–2.1; ALP: 42.0–135.4U/L. The RIs of albumin, globulin, A/G ratio, AST, ALT, and AST/ALT ratio differed significantly (p < 0.05) between males and females. Moreover, calculated out-of-range values showed that up to 4–40% of apparently healthy adults were classified as having abnormal test results based on current RIs. The newly established RIs fulfil the need for population and platform-specific RIs for the adult population of Gandaki Province of Nepal and bring more conformity and accuracy in interpreting the LFT results, diagnosis of hepatobiliary diseases, clinical decision-making, monitoring the success of therapy and future liver specific biomedical researches within the Gandaki Province of Nepal.

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, LIX1 (limb and CNS expressed 1) [NCBI Gene 167410] {aka C5orf11, Lft}
- **Diseases:** hepatobiliary diseases (MESH:D004066)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11081272/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11081272/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC11081272/full.md

---
Source: https://tomesphere.com/paper/PMC11081272